C12Y 305/01024
Choloylglycine hydrolase , i.e. bile salt hydrolase
Official title: Choloylglycine hydrolase (3.5.1.24), i.e. bile salt hydrolase
C12Y305/01024 (Choloylglycine hydrolase , i.e. bile salt hydrolase) appears on 6 US grants and 12 published applications in this corpus.
Search patents in C12Y- Granted patents
- 6
- Published applications
- 12
- Assignees
- 10
- Inventors
- 27
- Latest grant
- 26 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 1 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 1 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 0 | 1 |
| 2021 | 1 | 2 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Clostridioides difficile26 Aug 2025US 12,397,045 B2Imperial College of Science, Technology and Medicine
- Compositions for the inhibition of Giardia lamblia31 Aug 2021US 11,103,564 B2Ecole Nationale Veterinaire D' Alfort
- Compositions for the inhibition of Giardia lamblia25 Jun 2019US 10,328,132 B2Ecole Nationale Veterinaire D' Alfort
- Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides2 May 2017US 9,637,729 B2UAS Laboratories LLC
- Cell and enzyme compositions for modulating ale acids, cholesterol and triglycerides13 Jan 2015US 8,932,578 B2UAS Laboratories LLC
- Modified bile salt hydrolase enzymes and methods of using the same13 Aug 2026US 2026/0234596 A1Purpose Bio, Inc.
- Compositions and methods for modifying bile acids to regulate lipid and steroid metabolism11 Dec 2025US 2025/0375505 A1The Regents of the University of California
- Engineered dysbiosis-sensing probiotic for clostridium difficile infections and recurring infections management7 Apr 2022US 2022/0106603 A1National University of Singapore
- Compositions for the inhibition of giardia lamblia30 Dec 2021US 2021/0401954 A1Ecole Nationale Veterinaire D' Alfort
- Clostridioides difficile22 Apr 2021US 2021/0113671 A1Imperial College of Science, Technology and Medicine
Most cited
By later US patents
- Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides56US 7,939,061 B2Micropharma Limited · 2011
- Cell and enzyme compositions for modulating ale acids, cholesterol and triglycerides7US 8,932,578 B2UAS Laboratories LLC · 2015
- Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides6US 9,637,729 B2UAS Laboratories LLC · 2017
- Compositions for the inhibition of Giardia lamblia2US 10,328,132 B2Ecole Nationale Veterinaire D' Alfort · 2019